2025-02-01 2025-12-31 false Capium Accounts Production 1.1 12406787 2025-02-01 2025-12-31 12406787 bus:FullAccounts 2025-02-01 2025-12-31 12406787 bus:FRS102 2025-02-01 2025-12-31 12406787 bus:AuditExemptWithAccountantsReport 2025-02-01 2025-12-31 12406787 bus:SmallCompaniesRegimeForAccounts 2025-02-01 2025-12-31 12406787 bus:PrivateLimitedCompanyLtd 2025-02-01 2025-12-31 12406787 2025-02-01 2025-12-31 12406787 2025-12-31 12406787 bus:RegisteredOffice 2025-02-01 2025-12-31 12406787 core:WithinOneYear 2025-12-31 12406787 core:AfterOneYear 2025-12-31 12406787 1 2025-02-01 2025-12-31 12406787 bus:Director1 2025-02-01 2025-12-31 12406787 bus:Director1 2025-12-31 12406787 bus:Director1 2024-02-01 2025-01-31 12406787 2024-02-01 12406787 bus:LeadAgentIfApplicable 2025-02-01 2025-12-31 12406787 2024-02-01 2025-01-31 12406787 2025-01-31 12406787 core:WithinOneYear 2025-01-31 12406787 core:AfterOneYear 2025-01-31 12406787 bus:EntityAccountantsOrAuditors 2024-02-01 2025-01-31 12406787 core:ComputerEquipment 2025-02-01 2025-12-31 12406787 core:ComputerEquipment 2025-12-31 12406787 core:ComputerEquipment 2025-01-31 12406787 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-12-31 12406787 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-01-31 12406787 core:CostValuation core:Non-currentFinancialInstruments 2025-12-31 12406787 core:CostValuation core:Non-currentFinancialInstruments 2025-01-31 12406787 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-12-31 12406787 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-12-31 12406787 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-12-31 12406787 core:Non-currentFinancialInstruments 2025-12-31 12406787 core:Non-currentFinancialInstruments 2025-01-31 12406787 core:ShareCapital 2025-12-31 12406787 core:ShareCapital 2025-01-31 12406787 core:RetainedEarningsAccumulatedLosses 2025-12-31 12406787 core:RetainedEarningsAccumulatedLosses 2025-01-31 12406787 dpl:Item1 2025-02-01 12406787 dpl:Item1 2025-12-31 12406787 dpl:Item1 2024-02-01 12406787 dpl:Item1 2025-01-31 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 12406787
England and Wales
CARESENSE HEALTHCARE LTD.
Unaudited Financial Statements
Period of accounts Start date: 01 February 2025 End date: 31 December 2025

Caresense Healthcare Ltd. Contents Page For the Period 01 February 2025 to 31 December 2025
Company information | 1
Director's report | 2
Accountants' report | 3
Statement of financial position | 4
Notes to the financial statements | 5

Caresense Healthcare Ltd. Company Information For the Period 01 February 2025 to 31 December 2025
Director | Moilla Dzvanga
Registered Number | 12406787
Registered Office | 10 Oxford street Rothwell Kettering NN14 6HA
Accountants | VCK Accounting services Union house 111 New union street Coventry CV1 2NT
1

Caresense Healthcare Ltd. Director's Report For the Period 01 February 2025 to 31 December 2025
Director's report and financial statements The director presents his/her/their annual report and the financial statements for the year ended 31 December 2025 Principal activities The companys principal activity during the year was of other letting and operating of own or leased real estate Director The director who served the company throughout the period was as follows:
Moilla Dzvanga
Statement of director's responsibilities The director is responsible for preparing the directors’ report and the financial statements in accordance with applicable law and regulation. Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the director must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the director is required to select suitable accounting policies and then apply them consistently make judgments and accounting estimates that are reasonable and prudent prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business The director is responsible for keeping adequate accounting records that disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. The director is also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. The director is responsible for the maintenance and integrity of the corporate and financial information included on the company's website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions. Cessation of trading The company ceased trading on 31st December 2025 On behalf of the board.
---------------------------------- Moilla Dzvanga Director
Date approved: 21 January 2026 2

Caresense Healthcare Ltd. Accountants' Report For the Period 01 February 2025 to 31 December 2025
Accountant’s report You consider that the company is exempt from an audit for the year ended 31 December 2025 . You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year. In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us. We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts. VCK Accounting services 31 December 2025 .................................................... VCK Accounting services Union house 111 New union street Coventry CV1 2NT 21 January 2026 3

Caresense Healthcare Ltd. Statement of Financial Position As at 31 December 2025
| Notes | 2025 £ |  | 2025 £
--- | --- | --- | --- | ---
Fixed assets |  |  |
Tangible fixed assets | 3 | 0 |  | 280
|  | 0 |  | 280
Current assets |  |  |
Debtors | 4 | 2,511 |  | 4,523
Cash at bank and in hand |  | 815 |  | 238
|  | 3,326 |  | 4,761
Creditors: amount falling due within one year | 5 | 0 |  | (550)
Net current assets |  | 3,326 |  | 4,211
Total assets less current liabilities |  | 3,326 |  | 4,491
Creditors: amount falling due after more than one year | 6 | (9,227) |  | (4,956)
Net assets |  | (5,901) |  | (465)
Capital and reserves |  |  |
Called up share capital |  | 2 |  | 2
Profit and loss account |  | (5,903) |  | (467)
Shareholders' funds |  | (5,901) |  | (465)
For the period ended 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Director's responsibilities: The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies. The financial statements were approved by the director on 21 January 2026 and were signed by:
------------------------------- Moilla Dzvanga Director
4

Caresense Healthcare Ltd. Notes to the Financial Statements For the Period 01 February 2025 to 31 December 2025
General Information Caresense Healthcare Ltd. is a private company, limited by shares, registered in England and Wales, registration number 12406787, registration address 10 Oxford street, Rothwell, Kettering, NN14 6HA. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by Section 1A of the standard) Closure The financial statements have been prepared under the realisation basis. Turnover Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts. Taxation Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date. Current and deferred tax assets and liabilities are not discounted Tangible fixed assets Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
2. | Average number of employees Average number of employees during the period was 1 (2025 : 2).
3. | Tangible fixed assets
Cost or valuation | Computer Equipment |  | Total
| £ |  | £
At 01 February 2025 | 325 |  | 325
Additions | - |  | -
Disposals | (325) |  | (325)
At 31 December 2025 | - |  | -
Depreciation
At 01 February 2025 | 45 |  | 45
Charge for period | - |  | -
On disposals | (45) |  | (45)
At 31 December 2025 | - |  | -
Net book values
Closing balance as at 31 December 2025 | - |  | -
Opening balance as at 01 February 2025 | 280 |  | 280
4. | Debtors: amounts falling due after one year
| 2025 £ |  | 2025 £
--- | --- | --- | ---
Other Debtors | 2,511 |  | 4,523
| 2,511 |  | 4,523
5. | Creditors: amount falling due within one year
| 2025 £ |  | 2025 £
--- | --- | --- | ---
Accrued Expenses | 0 |  | 550
| 0 |  | 550
6. | Creditors: amount falling due after more than one year
| 2025 £ |  | 2025 £
--- | --- | --- | ---
Other Creditors | 2,665 |  | 2,325
Directors' Loan Accounts | 6,562 |  | 2,631
| 9,227 |  | 4,956
7. | Advances and Credits Moilla Dzvanga
Current year (2025)
| Brought Forward £ | Amount £ | Interest £ | Repaid £ | Written Off £ | Waived £ | Carry Forward £
--- | --- | --- | --- | --- | --- | --- | ---
Moilla Dzvanga | (2,631) |  | 2,377 |  | 0 |  | 6,308 |  | 0 |  | 0 |  | (6,562)
| -2631 |  | 2377 |  | 0 |  | 6308 |  | 0 |  | 0 |  | -6562
Previous year (2025)
| Brought Forward £ | Amount £ | Interest £ | Repaid £ | Written Off £ | Waived £ | Carry Forward £
--- | --- | --- | --- | --- | --- | --- | ---
Moilla Dzvanga | (2,631) |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | (2,631)
| -2631 |  | 0 |  | 0 |  | 0 |  | 0 |  | 0 |  | -2631
5